Maven Securities LTD acquired a new stake in shares of Enovix Co. (NASDAQ:ENVX – Free Report) in the third quarter, Holdings Channel reports. The fund acquired 30,000 shares of the company’s stock, valued at approximately $280,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Driehaus Capital Management LLC boosted its position in shares of Enovix by 63.7% during the 2nd quarter. Driehaus Capital Management LLC now owns 3,886,492 shares of the company’s stock valued at $60,085,000 after purchasing an additional 1,512,424 shares in the last quarter. Fred Alger Management LLC raised its holdings in Enovix by 2,468.6% during the 3rd quarter. Fred Alger Management LLC now owns 588,614 shares of the company’s stock worth $5,498,000 after buying an additional 565,698 shares during the period. Old West Investment Management LLC lifted its stake in Enovix by 47.6% during the second quarter. Old West Investment Management LLC now owns 835,386 shares of the company’s stock valued at $12,915,000 after buying an additional 269,371 shares in the last quarter. Sanctuary Advisors LLC acquired a new position in shares of Enovix in the second quarter worth about $1,867,000. Finally, Meridian Wealth Management LLC purchased a new position in shares of Enovix in the third quarter worth approximately $1,066,000. 50.92% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
ENVX has been the subject of a number of recent analyst reports. Janney Montgomery Scott lowered shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective for the company. in a research note on Thursday, October 31st. Benchmark reiterated a “buy” rating and set a $25.00 price target on shares of Enovix in a report on Wednesday, October 30th. Oppenheimer reissued an “outperform” rating and issued a $36.00 price objective on shares of Enovix in a research note on Monday, August 26th. JPMorgan Chase & Co. decreased their price objective on Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 target price on shares of Enovix in a report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $20.50.
Enovix Trading Down 7.6 %
Shares of NASDAQ:ENVX opened at $9.30 on Friday. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The stock has a market capitalization of $1.66 billion, a PE ratio of -5.78 and a beta of 1.94. Enovix Co. has a 1 year low of $5.70 and a 1 year high of $18.68. The firm has a fifty day moving average price of $10.12 and a 200 day moving average price of $11.32.
Enovix (NASDAQ:ENVX – Get Free Report) last issued its quarterly earnings data on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.03. The business had revenue of $4.30 million for the quarter, compared to analyst estimates of $4.11 million. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. During the same quarter in the prior year, the firm posted ($0.27) EPS. Analysts expect that Enovix Co. will post -1.17 EPS for the current fiscal year.
Insider Transactions at Enovix
In other Enovix news, insider Arthi Chakravarthy sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $13.00, for a total value of $455,000.00. Following the sale, the insider now owns 343,305 shares of the company’s stock, valued at $4,462,965. This trade represents a 9.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Betsy S. Atkins sold 75,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total value of $729,750.00. Following the transaction, the director now owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. This trade represents a 42.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 15.70% of the stock is owned by corporate insiders.
Enovix Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Recommended Stories
- Five stocks we like better than Enovix
- 5 Top Rated Dividend Stocks to Consider
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Retail Stocks Investing, Explained
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- What Are Growth Stocks and Investing in Them
- BlackRock Makes Waves With $12B Private Credit Acquisition
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.